- Telehealth available in California, Florida, and Oregon, Arizona
Does low testosterone cause hair loss, and is there actually a connection worth investigating? If you are noticing hair thinning alongside fatigue or reduced energy, the relationship between low testosterone and hair loss may be more nuanced than you expect.
The answer is not a simple yes or no. Testosterone itself does not directly cause hair loss. But the hormonal chain that testosterone is part of plays a central role in the most common form of male hair loss. Understanding that chain and how low testosterone fits into it gives you a more accurate clinical picture.
This guide explains the relationship between low testosterone and hair loss, what DHT has to do with it, how genetics shape the outcome, and what a clinical evaluation covers.
Hair loss is one of the symptoms men most commonly associate with hormonal changes. For many men, the first question after noticing increased shedding or a receding hairline is whether their testosterone levels are involved.
This association is not unfounded. Testosterone is a precursor to dihydrotestosterone, the androgen most directly linked to androgenetic alopecia. Low testosterone symptoms including fatigue, reduced motivation, and mood changes frequently accompany the kind of hair thinning that suggests hormonal involvement.
For men also experiencing fatigue alongside hair thinning, the Low Energy and Fatigue conditions page covers how hormonal deficiency affects energy and what evaluation involves.
The clinical reality is that low testosterone and hair loss are connected, but not in the straightforward way most men assume. The connection runs through a conversion process that transforms testosterone into a more potent androgen. Whether that androgen causes hair loss depends heavily on genetics.
The relationship between low testosterone and hair loss is indirect but clinically meaningful. It helps to know what happens to testosterone after it enters the bloodstream.
A portion of circulating testosterone is converted by an enzyme called 5-alpha reductase into dihydrotestosterone, or DHT. DHT is significantly more potent than testosterone in its effects on androgen-sensitive tissues. In men with a genetic predisposition to androgenetic alopecia, DHT binds to receptors in scalp hair follicles and triggers progressive miniaturization.
According to research published by the National Institutes of Health, young men with androgenetic alopecia showed significantly higher serum levels of free testosterone and DHT compared to controls. Patients who showed greater reductions in DHT after treatment had higher rates of improvement in hair loss severity.
This creates a counterintuitive picture for low testosterone and hair loss. Because DHT is derived from testosterone, low testosterone can mean lower DHT production. In theory, lower DHT should mean less follicle miniaturization. But the clinical reality is more complex because follicle sensitivity to DHT, determined largely by genetics, can vary dramatically between individuals.
DHT is the central driver of androgenetic alopecia, the most common form of hair loss in men. Understanding how DHT affects hair follicles explains why the connection between low testosterone and hair loss is so often misunderstood.
DHT binds to androgen receptors in hair follicles with approximately five times greater affinity than testosterone. In genetically susceptible follicles, this binding shortens the hair growth cycle and progressively miniaturizes the follicle. Over time, affected follicles produce increasingly fine, short, and colorless hair before eventually stopping production entirely.
According to the Cleveland Clinic, medical experts think there is a link between DHT and hair follicle shrinking. The AR gene’s sensitivity helps determine male pattern baldness. This genetic sensitivity to DHT is the primary reason some men lose significant hair while others with similar DHT levels do not.
Key facts about DHT and androgenetic alopecia:
Testosterone levels alone are a poor predictor of androgenetic alopecia. Genetics and follicle sensitivity play a far greater role.
According to Mayo Clinic Proceedings, male pattern baldness is known to depend on DHT and on a genetic predisposition for this condition. DHT is synthesized from testosterone by 5-alpha reductase, with the type 2 isoform expressed in hair follicles appearing more important than type 1 in male pattern baldness.
The AR gene on the X chromosome, inherited from the mother, encodes the androgen receptor. Variations in this gene determine how sensitively a man’s hair follicles respond to DHT. A man with highly sensitive receptors may lose significant hair even with modest testosterone and DHT levels. A man with less sensitive receptors may retain most of his hair despite higher androgen levels.
This genetic dimension explains several commonly observed patterns:
The concern that testosterone replacement therapy causes or accelerates hair loss is one of the most common questions men have before starting treatment.
TRT raises circulating testosterone levels. A portion of that testosterone converts to DHT through 5-alpha reductase. In men who are genetically predisposed to androgenetic alopecia, this increase in available DHT can accelerate the progression of hair loss that was already occurring or would have occurred regardless of treatment.
In men who are not genetically predisposed, the evidence does not support TRT as a meaningful cause of hair loss. The genetic sensitivity of the follicle to DHT is the deciding factor, not the testosterone level itself.
For men who want to understand the broader range of changes that occur during TRT, the What Happens to Your Body in the First 90 Days of TRT guide covers what to expect across skin, hair, mood, and body composition during early treatment.
The practical clinical picture for men considering TRT who are concerned about hair loss:
Not all hair thinning in men is androgenetic alopecia. Several other hormonal conditions can cause hair loss that mimics or compounds the pattern associated with low testosterone and hair loss.
Thyroid dysfunction is one of the most common non-androgenic causes of hair thinning in men. Both hypothyroidism and hyperthyroidism can cause diffuse hair shedding. This type of thinning is typically more even across the scalp rather than following the classic frontal and crown recession pattern of androgenetic alopecia. Thyroid-related hair thinning is reversible when thyroid function is restored to normal.
Elevated cortisol from chronic stress can push hair follicles prematurely into the telogen resting phase, causing a type of shedding called telogen effluvium. This differs from androgenetic alopecia in that it produces generalized shedding rather than patterned thinning. It is also more reversible when the underlying stress physiology is addressed.
Nutritional deficiencies including low ferritin, zinc, vitamin D, and biotin are associated with hair thinning in men. These are frequently identified alongside hormonal imbalances and can compound the degree of thinning a man experiences.
Low testosterone itself can contribute to hair thinning through a different mechanism than DHT-driven androgenetic alopecia. Low testosterone is associated with reduced anabolic signaling, which can affect hair quality, growth rate, and thickness independently of the DHT conversion pathway.
For men who want to understand how a comprehensive hormone evaluation is approached within a functional medicine program, the Hormone Replacement Therapy service page outlines what the assessment process involves and what personalized hormone care looks like.
For men experiencing low testosterone and hair loss together, the most clinically useful step is a comprehensive evaluation that assesses both the hormonal and non-hormonal factors contributing to the pattern.
A thorough evaluation typically includes:
Understanding the cause of hair thinning accurately is the prerequisite for choosing the right treatment approach. Treating androgenetic alopecia with nutritional supplementation when DHT-driven follicle miniaturization is the cause produces limited results. Treating presumed androgenetic alopecia with DHT-blocking medications when thyroid dysfunction is the actual driver does not address the underlying problem either.
Not directly. The connection between low testosterone and hair loss runs through its conversion to DHT and the genetic sensitivity of individual follicles to DHT's effects. Follicle sensitivity matters more than testosterone or DHT levels alone.
It depends on the cause of the hair thinning. If hair loss is driven by androgenetic alopecia and significant follicle miniaturization has already occurred, restoring testosterone to normal levels will not regrow hair in those follicles. If hair thinning is related to thyroid dysfunction, nutritional deficiency, or telogen effluvium, addressing those root causes can result in meaningful regrowth.
This depends on your genetic predisposition, the severity of your testosterone deficiency symptoms, and how much you value hair retention relative to the benefits of treatment. Men without a genetic predisposition are unlikely to experience meaningful hair loss from TRT. Men with a strong family history and early signs of thinning should discuss the risk with their provider and explore adjunctive treatments.
Hair loss accelerated by TRT in genetically predisposed men is typically permanent in the follicles that have undergone significant miniaturization. This is the same prognosis as androgenetic alopecia progressing without TRT. Stopping TRT may slow further progression but is unlikely to reverse hair loss that has already occurred.
5-alpha reductase inhibitors including finasteride and dutasteride reduce DHT production and are the most clinically established pharmacological treatments for androgenetic alopecia. They work by blocking the enzyme that converts testosterone to DHT. Topical minoxidil is commonly used alongside these medications to support follicle health and extend the growth phase of the hair cycle.
Yes. When hair thinning is related to thyroid dysfunction, elevated cortisol, or nutritional deficiencies, addressing those underlying factors can produce meaningful improvements in hair density and quality. A comprehensive hormonal evaluation is more clinically useful than testing testosterone in isolation when hair loss is the presenting concern.
The relationship between low testosterone and hair loss is real but indirect. It involves DHT conversion, follicle sensitivity, genetic predisposition, and multiple other hormonal variables that a single testosterone measurement cannot capture. Getting accurate answers requires looking at the full hormonal picture rather than focusing on one number.
For men in Southern California who want to understand how testosterone, DHT, thyroid function, and related hormonal factors are evaluated as part of a comprehensive approach, TRT in Mission Viejo, CA outlines what a thorough hormonal evaluation involves and what personalized testosterone care looks like in a functional medicine setting.
Hair thinning in men is rarely caused by a single factor. Understanding where testosterone and DHT fit in the picture, alongside thyroid function, stress physiology, and genetics, is the starting point for any meaningful clinical response to hair loss.
The information provided in this article is intended for educational purposes only and does not constitute medical advice. Hair loss and hormonal imbalances are medical conditions requiring evaluation and treatment by a licensed healthcare provider. Do not start, stop, or adjust any hormone therapy or hair loss treatment without consulting your provider directly.
Wu Y, et al. Androgens and androgenetic alopecia in young Chinese males. PMC, National Institutes of Health. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6223099/
Cleveland Clinic Medical Staff. Male pattern baldness (androgenic alopecia): Stages, treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24515-male-pattern-baldness-androgenic-alopecia
Blumeyer A, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clinic Proceedings. 2011. https://www.mayoclinicproceedings.org/article/S0025-6196(11)61759-X/fulltext
